MERIT Acquires OSOD, Expanding Capabilities in Early-Stage Drug Development
This strategic acquisition enhances MERIT's service offerings, enabling a seamless transition from preclinical to clinical phases of drug development. MADISON, WI, UNITED STATES, January 22, 2025 /EINPresswire.com/ -- MERIT, a global clinical trial …